Lisa Graver

Lisa Graver

Chief Executive Officer at ALVOTECH

Net worth: 106 667 $ as of 2026-05-30

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Lisa Graver is currently Chief Executive Officer at Norwich Pharmaceuticals, Inc., Chief Executive Officer at Alvotech (title starting 2026), Director at Alvotech hf, and President at Almaject, Inc. Former positions include Chief Executive Officer at Alvogen, Inc. from 2010 to 2025, Chief Executive Officer at Alvogen Pharma US, Inc., Senior Director & VP-Intellectual Property at Actavis, Inc. from 2006 to 2008, and Associate at Kirkland & Ellis LLP.
Education includes undergraduate studies at the University of Lakehead and graduate studies at Case Western Reserve University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-05 31,746 ( 0.01% ) 106 667 $ 2026-05-30

Lisa Graver active positions

CompaniesPositionStart
ALVOTECH Chief Executive Officer 2026-02-28
President -
Chief Executive Officer -
Director/Board Member -

Former positions of Lisa Graver

CompaniesPositionEnd
Chief Executive Officer 2025-11-30
Chief Executive Officer 2025-11-30
Corporate Officer/Principal 2007-12-31
Corporate Officer/Principal -
See the detail of Lisa Graver's experience

Training of Lisa Graver

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology